Sommerer C, Legendre C, Citterio F, Watarai Y, et al. Cardiovascular Outcomes in De Novo Kidney Transplant Recipients Receiving Everolimus and Reduced Calcineurin Inhibitor or Standard Triple Therapy: 24-month Post Hoc Analysis From TRANSFORM Study. Transplantation 2023 Mar 24. doi: 10.1097/TP.0000000000004555.
PMID: 36959121